论文部分内容阅读
目的:观察中药扶正介入治疗晚期非小细胞肺癌(NSCLC)的疗效。方法:将64例晚期非小细胞肺癌患者随机分为治疗组34例和对照组30例。治疗组用中药扶正和介入疗法,对照组单用介入疗法,疗程3周至6周。结果:治疗组总有效率为47%,对照组为23%。两组比较差异有显著性意义(P<0.05)。结论:中药扶正介入治疗晚期非小细胞肺癌有确切的临床价值。
Objective: To observe the curative effect of Fuzhong interventional therapy on advanced non-small cell lung cancer (NSCLC). Methods: 64 patients with advanced non-small cell lung cancer were randomly divided into treatment group 34 cases and control group 30 cases. The treatment group was treated with traditional Chinese medicine and interventional therapy, the control group with interventional therapy alone, the course of 3 weeks to 6 weeks. Results: The total effective rate was 47% in the treatment group and 23% in the control group. There was significant difference between the two groups (P <0.05). Conclusion: Chinese medicine Fuzheng interventional treatment of advanced non-small cell lung cancer have a definite clinical value.